Stock Price

As AI tools offer students instant answers, EdTech firm Thea has served a billion questions instead. We investigate its 'Socratic' model and its ambitious bid to rewire learning.

CrowdStrike reports record earnings and a stock split, but its true story lies in deep AI pacts with OpenAI. Is it enough to secure the AI frontier?

The discount retailer shattered expectations with a 32.5% sales jump. We go beyond the numbers to see how its strategy offers a masterclass in today's economy.

As CEO Reshma Kewalramani takes the stage, investors will look for clues on how Vertex plans to pivot from CF dominance to a multi-franchise powerhouse.

Fairplay's new user verification signals a market-wide shift. As India's stringent new rules take hold, compliance is becoming a key strategic asset.

AM Best affirms Fairfax's 'Excellent' rating after a year of record profits and major catastrophes. We deconstruct the strategy behind this financial paradox.

As its CEO takes the stage at a key defense summit, a look at how Palladyne AI's pivot from hardware to 'embodied AI' and vertical integration is creating a new model for a defense tech prime.

The new INYY ETF promises massive income from Intel's volatility. But a look under the hood reveals NAV erosion, capped gains, and a return of your own capital.

As it marks 30 years, Bread Financial steps onto a major stage. Behind the standard announcement lies a story of tech-driven resurgence and strategic focus.

Recognized by TIME as a top global growth leader, GigaCloud isn't just collecting awards. Its success reveals a powerful B2B logistics model rewriting the rules.

Amaze Holdings partners with BBR Music Group to overhaul merch with a low-risk model. But can this innovative play overcome the company's financial pressures?

Vision Marine's new Dania Beach hub isn't just a store; it's a strategic play to merge retail, service, and on-water demos to win the electric boat race.

A new report shows California's self-insured employers face a puzzling trend: workers' comp claims are at a 5-year low, yet costs are surging. Why?

ArtHaus Partners' return to SF with its acquisition of The Terraces highlights a city in flux: an AI-fueled market boom clashing with tenant protections.

As The Conference Board honors S&P Global and UL Solutions, it’s clear that investing in people is no longer a soft skill—it's the core of modern strategy.

Bluejay Diagnostics secures critical funding to advance its rapid sepsis test, extending its cash runway but raising questions about shareholder dilution.

Stonegate Capital's updated coverage validates AB Science's pivot to ALS and AML, but can its promising clinical assets and shrewd financing de-risk the path forward?

As its CEO heads to a top investor conference, Zealand Pharma leverages AI and novel peptides to challenge giants in the multi-billion-dollar obesity market.

A negative outlook from AM Best reveals deep-seated risks in Colombia, where inflation, political uncertainty, and climate change threaten stability.

Jianzhi Education secures $5M in a deal that halves its stock price, revealing a clash between urgent capital needs and a long-term vision for AI innovation.